amlodipine has been researched along with avapro in 73 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.74) | 18.2507 |
| 2000's | 33 (45.21) | 29.6817 |
| 2010's | 30 (41.10) | 24.3611 |
| 2020's | 8 (10.96) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ruilope, LM | 1 |
| Lim, PO; MacDonald, TM; Naas, AA; Nys, M; Osbakken, M; Struthers, AD | 1 |
| Anzalone, DA; Atkins, RC; Clarke, WR; Hunsicker, LG; Lewis, EJ; Ritz, E; Rodby, RA; Rohde, RD | 1 |
| Atkins, RC; Berl, T; Clarke, WR; Hunsicker, LG; Lewis, EJ; Lewis, JB; Pohl, MA; Raz, I; Ritz, E; Rohde, R | 1 |
| Hunsicker, LG; Lewis, EJ; Rodby, RA | 1 |
| Brosnan, MJ; Dominiczak, AF; Graham, D; Hamilton, CA; Jardine, E; Lygate, CA | 1 |
| Studney, D | 1 |
| Suzuki, H | 2 |
| Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Berl, T; Drury, PL; Esmatjes, E; Goldhaber, SZ; Hricik, D; Hunsicker, LG; Lewis, EJ; Lewis, JB; Locatelli, F; Parikh, CR; Pfeffer, MA; Porush, JG; Raz, I; Rouleau, JL; Vanhille, P; Wiegmann, TB; Wolfe, BM | 1 |
| Annemans, L; Borenstein, J; Chen, RS; Chiou, CF; Lewis, EJ; Palmer, AJ; Rodby, RA; Roze, S; Sengupta, N; Simon, TA; Smitten, A | 1 |
| Bianchetti, MG; Edefonti, A; Fossali, E; Gartenmann, AC; Schmidtko, J; Simonetti, GD; von Vigier, RO | 1 |
| Fedele, F; Fera, MS; Ferri, FM; Gaudio, C; Giovannini, M; Pannarale, G; Puddu, PE; Vittore, A; Vizza, CD | 1 |
| Lewis, EJ; Lewis, JB | 1 |
| Annemans, L; Lamotte, M; Palmer, AJ; Ritz, E; Rodby, RA; Roze, S | 1 |
| Ruilope, LM; Segura, J | 1 |
| Coyle, D; Rodby, RA | 1 |
| Allen, TJ; Candido, R; Cao, Z; Cooper, ME; Jandeleit-Dahm, KA; Lassila, M; Thallas, V | 1 |
| Annemans, L; Bilous, RW; Lamotte, M; Palmer, AJ; Rodby, RA; Roze, S | 1 |
| Atkins, RC; Braden, G; Briganti, EM; Champion de Crespigny, PJ; DeFerrari, G; Drury, P; Hunsicker, LG; Lewis, EJ; Lewis, JB; Locatelli, F; Wiegmann, TB | 1 |
| Blumenthal, S; Cordonnier, DJ; De Alvaro, F; de Faria, JB; Deferrari, G; Eisner, G; Esmatjes, E; Gilbert, RE; Hunsicker, LG; Lewis, EJ; Mangili, R; Moore, J; Pohl, MA; Reisin, E; Ritz, E; Rodby, RA; Schernthaner, G; Spitalewitz, S; Tindall, H | 1 |
| Bostom, AG; Friedman, AN; Hunsicker, LG; Selhub, J | 1 |
| Germino, FW; Neutel, JM; Smith, D | 1 |
| Burnier, M; Frei, A; Hess, B; Palmer, AJ | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Boye, SW; Engeli, S; Jordan, J; Keefe, DL; Le Breton, S | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Aubert, JF; Bouzourene, K; Hayoz, D; Mazzolai, L; Nussberger, J; Pellegrin, M | 1 |
| Busch, M; Franke, S; Rohde, RD; Stein, G; Wolf, G | 1 |
| Belousov, DIu; Belousov, IuB; Shestakova, MV | 1 |
| Jin, D; Miyazaki, M; Sakonjo, H; Takai, S | 1 |
| Adamis, G; Astriti, M; Choreftaki, T; Delis, V; Moustakas, G; Papaliodi, E; Sarri, K; Tzanetou, K | 1 |
| Berl, T; de Graeff, PA; de Zeeuw, D; Holtkamp, FA; Lambers Heerspink, HJ; Laverman, GD; Lewis, JB; Packham, D; Parving, HH; Remuzzi, G | 1 |
| Bamias, A; Constantinidis, C; Deliveliotis, C; Dimopoulos, MA; Karadimou, A; Lainakis, G; Manios, E; Michas, F; Zakopoulos, N | 1 |
| Fu, ST; Gu, XW; Han, P; Shang, W; Su, DF; Xie, HH; Xu, LP; Yang, CB; Zhang, W | 1 |
| Buyukhatipoglu, H; Kilisli, H; Sayiner, ZA; Tiryaki, O; Usalan, C | 1 |
| Bain, SC; Bilous, RW; Evans, M; Hogan, S | 1 |
| Bobrie, G | 2 |
| Chen, SL; Chen, XL; Liu, XY; Mei, WY; Xu, WM | 1 |
| Garnock-Jones, KP | 1 |
| Mori, M; Takahashi, S | 1 |
| Fujiwara, S; Fukui, M; Goda, A; Hirotani, S; Komamura, K; Koshiba, M; Lee-Kawabata, M; Masaki, M; Masuyama, T; Nakabo, A; Otsuka, M; Sugahara, M; Tsujino, T | 1 |
| Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
| Kobalava, ZhD | 1 |
| Hasegawa, Y; Katayama, T; Kim-Mitsuyama, S; Koibuchi, N; Kusaka, H; Lin, B; Ma, M; Nakagawa, T; Sueta, D; Toyama, K; Uekawa, K | 1 |
| Fukuda, H; Ishibashi, K; Ishimitsu, T; Nagao, M; Nukui, K; Sato, F; Uchida, M | 1 |
| Adachi, S; Fujisawa, K; Inoue, T; Kusumoto, T; Miura, S; Motozato, K; Saku, K; Shiga, Y | 1 |
| Argyropoulou, MI; Christopoulou, F; Elisaf, M; Kosta, P; Rizos, EC | 1 |
| Azizi, M; Bergerot, D; Blanchard, A; Bobrie, G; Courand, PY; Dubourg, J; Forni, V; Frank, M; Menard, J; Mendes, M | 1 |
| Atkins, E; Bennett, A; Burke, M; Chalmers, J; Chou, M; Chow, CK; Dehbi, HM; Hillis, G; Hilmer, S; Krum, H; Neal, B; Nelson, M; Patel, A; Peiris, D; Reid, CM; Rodgers, A; Rogers, K; Salam, A; Thakkar, J; Thom, S; Usherwood, T; Vo, K; Webster, R; Woodward, M | 1 |
| Hasegawa, S; Hoshide, S; Ishii, H; Kanda, K; Kanegae, H; Kario, K; Katsuya, T; Shiraiwa, T; Tomitani, N; Uchiyama, K; Yamagiwa, K; Yoshida, T | 1 |
| Asayama, K; Harasawa, S; Hirayama, A; Kushiro, T; Ohkubo, T; Oiwa, K; Okubo, K; Takahashi, A; Tanabe, A; Tani, S | 1 |
| Okamura, K; Okuda, T; Shirai, K; Totake, N; Urata, H | 1 |
| Fujimoto, K; Iwasa, A; Kaikita, K; Kajiwara, I; Koyama, J; Matsui, K; Matsumura, T; Morihisa, K; Morikami, Y; Ogawa, H; Tsujita, K; Tsunoda, R; Uemura, T; Yamabe, H | 1 |
| Asayama, K; Hanazawa, T; Hosaka, M; Imai, Y; Inoue, R; Obara, T; Ohkubo, T; Satoh, M; Watabe, D | 1 |
| Laurent, S; Mancia, G; Poulter, N | 1 |
| Hasebe, N; Koyama, S; Maruyama, J; Morimoto, H; Nakagawa, N; Nakamura, Y; Ogawa, Y; Ohta, T; Saijo, Y; Sato, N; Takeuchi, T; Uekita, K | 1 |
| Atkins, ER; Billot, L; Chalmers, J; Chow, CK; Hay, P; Hillis, GS; Neal, B; Nelson, M; Patel, A; Reid, CM; Rodgers, A; Schlaich, M; Usherwood, T; Webster, R | 1 |
| Dogan, A; Palabıyık, İM; Süslü, İ | 1 |
| Pathak, AS; Rojas, M; Stouffer, GA | 1 |
| Atkins, ER; Billot, L; Burke, M; Chalmers, J; Chow, CK; Hay, P; Hillis, GS; Neal, B; Nelson, MR; Patel, A; Reid, CM; Rodgers, A; Rogers, K; Schlaich, MP; Usherwood, T; Webster, R | 1 |
| El Mously, DA; El-Sayed, GM; Hassan, NY; Mostafa, NM | 1 |
| Chen, Y; Huang, M; Jiang, W; Li, A; Li, J; Li, X; Liang, Z; Liu, T; Peng, L; Tang, X; Wang, W; Yang, G; Yang, Q; Zhao, X | 1 |
| Liang, H; Tang, T; Xie, M | 1 |
13 review(s) available for amlodipine and avapro
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Renoprotection and renin-angiotensin system blockade in diabetes mellitus.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Renin-Angiotensin System; Tetrazoles | 1997 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
[Large scale clinical trials in prevention of end-stage renal disease due to type 2 diabetes with angiotensin receptor antagonists].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic; Tetrazoles | 2002 |
[Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Clinical Trials as Topic; Disease Progression; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Tetrazoles; Treatment Outcome | 2002 |
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil | 2002 |
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2003 |
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Topics: Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Proteinuria; Tetrazoles | 2003 |
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Heart Failure; Humans; Hypertension; Irbesartan; Losartan; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Stroke; Tetrazoles; Treatment Outcome | 2011 |
Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Irbesartan; Tetrazoles; Treatment Outcome | 2013 |
Pharmacological and clinical properties of AIMIX® combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials, Phase II as Topic; Drug Combinations; Drug Design; Humans; Hypertension; Irbesartan; Tablets; Tetrazoles; Treatment Outcome | 2013 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Network Meta-Analysis; Telmisartan; Tetrazoles; Valine; Valsartan | 2023 |
32 trial(s) available for amlodipine and avapro
| Article | Year |
|---|---|
Renoprotection and renin-angiotensin system blockade in diabetes mellitus.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Renin-Angiotensin System; Tetrazoles | 1997 |
Irbesartan reduces QT dispersion in hypertensive individuals.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Double-Blind Method; Electrocardiography; Female; Heart; Humans; Hypertension; Irbesartan; Male; Receptors, Angiotensin; Tetrazoles | 1999 |
The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group.
Topics: Adult; Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Irbesartan; Male; Middle Aged; Prospective Studies; Research Design; Survival Rate; Tetrazoles; Treatment Outcome | 2000 |
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
Topics: Adult; Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Tetrazoles | 2001 |
A clinical trial in type 2 diabetic nephropathy.
Topics: Adult; Aged; Amlodipine; Angiotensin Receptor Antagonists; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Prospective Studies; Proteinuria; Tetrazoles | 2001 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome | 2003 |
Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.
Topics: Adolescent; Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Child; Creatinine; Cytoprotection; Female; Humans; Hypertension; Irbesartan; Kidney; Male; Serum Albumin; Tetrazoles | 2003 |
Comparative effects of irbesartan versus amlodipine on left ventricular mass index in hypertensive patients with left ventricular hypertrophy.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Biphenyl Compounds; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Prospective Studies; Tetrazoles | 2003 |
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting.
Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Cohort Studies; Cost-Benefit Analysis; Diabetic Nephropathies; Double-Blind Method; Health Care Costs; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Markov Chains; Middle Aged; Models, Economic; Tetrazoles; Treatment Outcome; United Kingdom | 2004 |
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Amlodipine; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Male; Middle Aged; Proteinuria; Renal Insufficiency; Tetrazoles | 2005 |
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Diabetic Nephropathies; Double-Blind Method; Follow-Up Studies; Humans; Hypertension; Irbesartan; Tetrazoles | 2005 |
Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Arteriosclerosis; Biphenyl Compounds; Cardiovascular System; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Homocysteine; Humans; Irbesartan; Male; Middle Aged; Placebos; Risk Factors; Smoking; Tetrazoles; Treatment Outcome | 2005 |
Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2005 |
Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
Topics: Administration, Oral; Adult; Aged; Amides; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diastole; Double-Blind Method; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Obesity; Renin; Systole; Tetrazoles; Treatment Outcome | 2007 |
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Linear Models; Lysine; Male; Middle Aged; Statistics, Nonparametric; Tetrazoles | 2008 |
[Economics of nephroprotection in arterial hypertension and type 2 diabetes mellitus].
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Drug Costs; Humans; Hypertension; Irbesartan; Kidney Diseases; Tetrazoles; Valine; Valsartan | 2008 |
I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospec
Topics: Adult; Africa, Northern; Aged; Aged, 80 and over; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Drug Combinations; Female; Humans; Hypertension; Irbesartan; Lebanon; Male; Mexico; Middle Aged; Prospective Studies; Saudi Arabia; South America; Tetrazoles; Time Factors; Treatment Outcome; Young Adult | 2012 |
I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prosp
Topics: Adult; Africa, Northern; Aged; Aged, 80 and over; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Irbesartan; Lebanon; Male; Mexico; Middle Aged; Prospective Studies; Saudi Arabia; South America; Tetrazoles; Time Factors; Treatment Outcome | 2012 |
Clinical study of western medicine combined with Chinese medicine based on syndrome differentiation in the patients with polarized hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diastole; Drugs, Chinese Herbal; Female; Humans; Hypertension; Irbesartan; Male; Stroke Volume; Syndrome; Tetrazoles | 2012 |
Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Remodeling; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Female; Heart Atria; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Time Factors | 2014 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
[Fixed irbesartan/amlodipine combination: efficacy and safety of the use of four dosing regimens in patients with arterial hypertension].
Topics: Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Synergism; Essential Hypertension; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2014 |
Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).
Topics: Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Triglycerides; Uric Acid; Valsartan | 2016 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitorin
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Communication; Diuretics; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Trichlormethiazide | 2017 |
The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.
Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Irbesartan; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Tetrazoles; Trichlormethiazide; Urinalysis | 2018 |
Assessment of suitable antihypertensive therapies: Combination with high-dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI-AI study).
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Artificial Intelligence; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Irbesartan; Prospective Studies; Tetrazoles; Treatment Outcome; Uric Acid | 2020 |
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Bisoprolol; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Humans; Hypertension; Indapamide; Irbesartan; Outcome Assessment, Health Care; Sample Size | 2021 |
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
Topics: Amlodipine; Antihypertensive Agents; Australia; Bisoprolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Irbesartan; Male; Middle Aged; Treatment Outcome | 2021 |
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Irbesartan; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2023 |
30 other study(ies) available for amlodipine and avapro
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biological Availability; Biphenyl Compounds; Blood Pressure; Blood Vessels; Disease Models, Animal; Drug Therapy, Combination; Female; Hypertension; Immunohistochemistry; Irbesartan; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Nitric Oxide; Phosphoproteins; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Stroke; Superoxides; Tetrazoles | 2002 |
[Diabetic patient with hypertension takes A-I I blocker. Less likely dialysis].
Topics: Albuminuria; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Diabetes Complications; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Risk Factors; Tetrazoles | 2002 |
Summaries for patients. Effects of blood pressure drugs in patients with diabetes and kidney disease.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome | 2003 |
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Health Care Costs; Humans; Hypertension; Irbesartan; Life Expectancy; Male; Markov Chains; Middle Aged; Tetrazoles | 2003 |
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].
Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Computer Simulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Germany; Health Care Costs; Humans; Hypertension; Incidence; Irbesartan; Kidney Failure, Chronic; Kidney Transplantation; Male; Markov Chains; Renal Dialysis; Tetrazoles; Treatment Outcome | 2004 |
Economic evaluation of the use of irbesartan and amlodipine in the treatment of diabetic nephropathy in patients with hypertension in Canada.
Topics: Adult; Aged; Amlodipine; Biphenyl Compounds; Cohort Studies; Cost-Benefit Analysis; Diabetic Nephropathies; Drug Costs; Female; Health Care Costs; Humans; Hypertension; Irbesartan; Male; Markov Chains; Middle Aged; Ontario; Reference Values; Sensitivity and Specificity; Tetrazoles | 2004 |
Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Biphenyl Compounds; Calcium Channel Blockers; Cell Division; Chemokine CCL2; Collagen; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Gene Expression Regulation; Irbesartan; Macrophages; Male; Mice; Mice, Knockout; Proto-Oncogene Proteins c-sis; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Streptozocin; Tetrazoles; Vascular Cell Adhesion Molecule-1 | 2004 |
[Health economic consequences of the use of irbesartan in patients with type 2 diabetes, hypertension and nephropathy in Switzerland].
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cohort Studies; Cost Savings; Costs and Cost Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Kidney Transplantation; Markov Chains; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Renal Dialysis; Risk; Sensitivity and Specificity; Switzerland; Tetrazoles; Time Factors | 2006 |
What blood-pressure level provides greatest renoprotection in patients with diabetic nephropathy and hypertension?
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Tetrazoles | 2006 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles | 2008 |
Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Dihydropyridines; Drug Therapy, Combination; Gene Expression; Glomerulosclerosis, Focal Segmental; Hypertension; Irbesartan; Kidney Glomerulus; Male; NADPH Oxidases; Nitrophenols; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred Dahl; Tetrazoles; Transforming Growth Factor beta | 2010 |
Intestinal schistosomiasis caused by both Schistosoma intercalatum and Schistosoma mansoni.
Topics: Adult; Amlodipine; Animals; Biphenyl Compounds; Colon, Sigmoid; Colon, Transverse; Colonoscopy; Histocytochemistry; Humans; Irbesartan; Life Cycle Stages; Male; Praziquantel; Schistosoma; Schistosoma mansoni; Schistosomiasis mansoni; Tetrazoles | 2010 |
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Benzopyrans; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Carcinoma, Renal Cell; Ethanolamines; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Irbesartan; Male; Middle Aged; Nebivolol; Prevalence; Pyrroles; Reproducibility of Results; Sunitinib; Tetrazoles; Time Factors; Treatment Outcome | 2011 |
Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Baroreflex; Biphenyl Compounds; Blood Pressure; Drug Synergism; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Rats; Rats, Inbred SHR; Tetrazoles | 2011 |
Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Endothelium, Vascular; Female; Fibrinolysis; Humans; Hypertension; Irbesartan; Lisinopril; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Tetrazoles | 2012 |
Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Glomerular Filtration Rate; Humans; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Tetrazoles | 2012 |
Therapy with the Combination of Amlodipine and Irbesartan Has Persistent Preventative Effects on Stroke Onset Associated with BDNF Preservation on Cerebral Vessels in Hypertensive Rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Blood-Brain Barrier; Brain-Derived Neurotrophic Factor; Calcium Channel Blockers; Disease Models, Animal; Drug Therapy, Combination; Irbesartan; Rats; Rats, Inbred SHR; Stroke; Tetrazoles | 2016 |
The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Product Surveillance, Postmarketing; Proteinuria; Surveys and Questionnaires; Tetrazoles; Treatment Outcome; Uric Acid | 2015 |
Does this patient have hypertensive encephalopathy?
Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Brain; Carbazoles; Carvedilol; Computed Tomography Angiography; Confusion; Creatinine; Electrocardiography; Glomerular Filtration Rate; Hallucinations; Headache; Heart; Humans; Hydrochlorothiazide; Hypertension; Hypertensive Encephalopathy; Irbesartan; Magnetic Resonance Imaging; Male; Middle Aged; Propanolamines; Renal Artery Obstruction; Spironolactone; Tetrazoles; Ultrasonography | 2016 |
Copeptin is increased in resistant hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Pressure; Coronary Vasospasm; Diuretics; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Nephrons; Osmolar Concentration; Renin-Angiotensin System; Sex Factors; Tetrazoles; Vasopressins | 2016 |
Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Irbesartan; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; Uric Acid | 2018 |
Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Atrial Fibrillation; Biphenyl Compounds; Blood Pressure; C-Reactive Protein; Catheter Ablation; Electric Countershock; Electrocardiography, Ambulatory; Female; Heart Atria; Humans; Hypertension; Irbesartan; Male; Middle Aged; Prospective Studies; Recurrence; Tetrazoles; Treatment Outcome; Ventricular Function, Left | 2018 |
Perindopril 3.5 mg/amlodipine 2.5 mg versus renin-angiotensin system inhibitor monotherapy as first-line treatment in hypertension: a combined analysis.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Valsartan | 2018 |
Simultaneous Determination of Amlodipine and Irbesartan in their Pharmaceutical Formulations by Square-Wave Voltammetry.
Topics: Amlodipine; Drug Compounding; Electrodes; Irbesartan; Mercury | 2022 |
Expression of Cyr61 in ApoE
Topics: Amides; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Apolipoproteins E; Blood Pressure; Cysteine-Rich Protein 61; Fumarates; Gene Expression Regulation; Humans; Hypertension; Irbesartan; Mice; Mice, Knockout; Renal Artery; Renal Artery Obstruction | 2021 |
Different Approaches in Manipulating Ratio Spectra for Analyzing Amlodipine Besylate and Irbesartan Combination.
Topics: Amlodipine; Antihypertensive Agents; Humans; Hypertension; Irbesartan; Spectrophotometry; Tetrazoles | 2022 |